Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).

 

Brand: BCM

 

Target: Neprilysin

 

Signaling Pathways: Metabolism

 

In Vivo: Pharmacokinetics of Sacubitril, Sacubitrilat, and valsartan following the administration of single oral doses of LCZ696 400 or 1200 mg under fasting conditions are summarized. The mean plasma concentrations of Sacubitril increases rapidly with a median Tmax of 0.52 h for the 400 mg dose and 1.05 h for the 1200 mg dose, followed by Sacubitrilat, with the corresponding Tmax values of 2.07 and 3.05 h, respectively. The median Tmax for valsartan is 2.07 h for both the LCZ696 400 mg and 1200 mg doses. The Cmax of Sacubitrilat shows a dose-proportional increase, while the Cmax of Sacubitril and Valsartan shows less than proportional increases between the doses.

 

Boiling Point: 705.4±60.0 °C(Predicted)

 

pKa: 4.59±0.23(Predicted)

 

Solubility: Soluble in DMSO; Soluble in Ethanol. Insoluble in Water.

 

GHS: GHS07

 

Isomeric SMILES: C[C@H](C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O)C(=O)O  

 

InChIKey: DOBNVUFHFMVMDB-BEFAXECRSA-N  

 

InChI: InChI=1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1

 

Attribute
[Chem Name]	(2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid
[Synonym]	Sacubitrilat; Sac; LBQ-657
[CAS No.]	149709-44-4
[MDL No.]	MFCD00921225
[Formula]	C22H25NO5
[Molecular]	383.44
[Form]	A crystalline solid
[Storage]	Sealed in dry. Room Temperature

Goods Tag